HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)

HLB Pharmaceutical Revenue

HLB Pharmaceutical had revenue of 65.65B KRW in the quarter ending March 31, 2026, with 89.49% growth. This brings the company's revenue in the last twelve months to 236.59B, up 72.59% year-over-year. In the year 2025, HLB Pharmaceutical had annual revenue of 205.58B with 49.97% growth.

• Revenue (ttm): 236.59B
• Revenue Growth: +72.59%
• P/S Ratio: 0.65
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 153.90B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	205.58B	68.50B	49.97%
Dec 31, 2024	137.08B	100.98B	279.73%
Dec 31, 2019	36.10B	15.56B	75.75%
Dec 31, 2018	20.54B	4.98B	32.03%
Dec 31, 2017	15.56B	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 13, 2026

Data Sources Report a data error